Apple 因停产智能手表型号对 Masimo 提起 250 美元专利诉讼并获胜

陪审团认定，Masimo 侵犯了苹果公司与已不再上市的旧款智能手表中的健康技术相关的专利。

A Delaware jury has sided with Apple Inc. (NASDAQ:AAPL) in a patent infringement case against Masimo Corp. (NASDAQ:MASI), awarding the Cupertino company a symbolic $250 in damages.

特拉华州陪审团在针对 Masimo Corp.（纳斯达克股票代码：MASI）的专利侵权案中站在苹果公司（纳斯达克股票代码：AAPL）一边，判给这家库比蒂诺公司象征性的 250 美元赔偿金。

What Happened: The jury decided that Masimo infringed on Apple’s patents related to health technology in older smartwatch models that are no longer on the market, reported Reuters.

发生的事情：据路透社报道，陪审团裁定 Masimo 侵犯了苹果公司与已不再上市的旧款智能手表中的健康技术相关的专利。

The lawsuit, initiated by Apple in 2022, accused Masimo of infringing on two design patents to enhance its own smartwatch offerings. The jury found that Masimo’s discontinued Freedom and W1 smartwatches violated Apple’s patents, but current Masimo products were not found to infringe.

该诉讼由苹果公司于 2022 年发起，指控 Masimo 侵犯两项设计专利，以增强自己的智能手表产品。陪审团认定，Masimo 已停产的 Freedom 和 W1 智能手表侵犯了苹果公司的专利，但目前的 Masimo 产品并未被发现侵权。

Apple’s legal team sought an injunction against Masimo’s current products, but this request was denied by the jury. Apple expressed satisfaction with the ruling, stating it protects their innovations.

苹果的法律团队寻求针对 Masimo 当前产品的禁令，但这一请求被陪审团拒绝。苹果公司对裁决表示满意，称其保护了他们的创新。

"We're pleased that the jury found Masimo infringed on our patents and awarded damages. This verdict underscores the importance of protecting our innovations, which ultimately benefit our users."

“我们很高兴陪审团发现 Masimo 侵犯了我们的专利并判给我们赔偿。这一裁决强调了保护我们创新的重要性，这最终使我们的用户受益。”

Meanwhile, Masimo viewed the verdict as a victory, emphasizing that the infringement ruling applied only to outdated models.

与此同时，马西莫认为该判决是一次胜利，并强调侵权判决仅适用于过时的型号。

"We are pleased that the jury found no infringement of Apple's patents by any Masimo products currently on the market and that the verdict relates solely to two older models of smartwatches that Masimo discontinued several years ago."

“我们很高兴陪审团发现目前市场上的任何 Masimo 产品均未侵犯苹果的专利，并且该判决仅涉及 Masimo 几年前停产的两款旧款智能手表。”

See Also: Nvidia CEO Jensen Huang Meets Indian Billionaire Mukesh Ambani, Duo Forge Partnership To Build AI Infrastructure

另请参阅：Nvidia 首席执行官黄仁勋会见印度亿万富翁 Mukesh Ambani，Duo Forge 合作构建 AI 基础设施

The legal battle between Apple and Masimo has been ongoing, with Masimo previously accusing Apple of poaching its employees and copying its pulse oximetry technology.

苹果和 Masimo 之间的法律斗争一直在持续，Masimo 此前指控苹果挖走其员工并抄袭其脉搏血氧仪技术。

Masimo had filed a countersuit against Apple, alleging that the company stole trade secrets related to pulse oximetry technology for its Apple Watch. A Delaware jury rejected Masimo's claims in that case last year.

Masimo 对苹果公司提起反诉，指控该公司窃取了与 Apple Watch 脉搏血氧饱和度技术相关的商业机密。去年，特拉华州陪审团驳回了马西莫在此案中的主张。

Both companies are engaged in the development and sale of smartwatches and other wearable devices, making their legal dispute a point of contention in the consumer tech space.

两家公司都从事智能手表和其他可穿戴设备的开发和销售，这使得它们的法律纠纷成为消费科技领域的争论焦点。

Why It Matters: Earlier this year, Apple managed to avoid an import ban on its latest Apple Watch models by redesigning the product, a move that temporarily safeguarded its sales in the U.S. market. However, this decision is not final and could be challenged by the U.S. International Trade Commission.

重要性：今年早些时候，苹果通过重新设计产品成功避免了对其最新款 Apple Watch 的进口禁令，此举暂时保障了其在美国市场的销售。然而，这一决定不是最终决定，可能会受到美国国际贸易委员会的质疑。

In response to the looming ban, Apple released versions of its watches without the blood oxygen feature, ensuring continued sales in the U.S.

为了应对迫在眉睫的禁令，苹果发布了不带血氧功能的手表版本，以确保在美国的持续销售

This strategic adjustment highlights Apple’s adaptability in the face of legal challenges.

此次战略调整凸显了苹果面对法律挑战的适应能力。

Meanwhile, Masimo’s CEO Joe Kiani has publicly criticized the reliability of Apple's blood oxygen monitoring feature, underscoring the competitive tensions between the two firms.

与此同时，Masimo 的首席执行官 Joe Kiani 公开批评了苹果血氧监测功能的可靠性，凸显了两家公司之间的竞争紧张关系。